📈 Stocks
Latigo Biotech Files for $288M Nasdaq IPO to Fund Non-Opioid Pain Drugs
(38 minutes ago)
Latigo files for $288M US IPO to advance its non-opioid painkiller pipeline, capitalizing on strong investor interest in safer alternatives to addictive…